questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Génome microbien
Génome viral
Gènes viraux
Gènes vif
Gènes vif : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gènes vif : Questions médicales les plus fréquentes",
"headline": "Gènes vif : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gènes vif : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-02",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gènes vif"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gènes viraux",
"url": "https://questionsmedicales.fr/mesh/D005814",
"about": {
"@type": "MedicalCondition",
"name": "Gènes viraux",
"code": {
"@type": "MedicalCode",
"code": "D005814",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gènes vif",
"alternateName": "Genes, vif",
"code": {
"@type": "MedicalCode",
"code": "D016341",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel J Salamango",
"url": "https://questionsmedicales.fr/author/Daniel%20J%20Salamango",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: dsalaman@umn.edu."
}
},
{
"@type": "Person",
"name": "Reuben S Harris",
"url": "https://questionsmedicales.fr/author/Reuben%20S%20Harris",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: rsh@umn.edu."
}
},
{
"@type": "Person",
"name": "Yingxia Hu",
"url": "https://questionsmedicales.fr/author/Yingxia%20Hu",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA."
}
},
{
"@type": "Person",
"name": "Yong Xiong",
"url": "https://questionsmedicales.fr/author/Yong%20Xiong",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA. Electronic address: yong.xiong@yale.edu."
}
},
{
"@type": "Person",
"name": "Nicholas M Chesarino",
"url": "https://questionsmedicales.fr/author/Nicholas%20M%20Chesarino",
"affiliation": {
"@type": "Organization",
"name": "Divisions of Human Biology and Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Estimating reference intervals from an IPD meta-analysis using quantile regression.",
"datePublished": "2024-10-26",
"url": "https://questionsmedicales.fr/article/39462323",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-024-02378-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hospitalization costs of road traffic injuries in Hunan, China: A quantile regression analysis.",
"datePublished": "2023-10-30",
"url": "https://questionsmedicales.fr/article/37907040",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aap.2023.107368"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37863117",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2023.09.064"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between obsessive compulsive symptomatology and severity of psychotic symptoms in schizophrenia: Meta-analysis and meta-regression analysis.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36549240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.schres.2022.12.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endoscopic third ventriculostomy for shunt malfunction in the pediatric population: a systematic review, meta-analysis, and meta-regression analysis.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36787128",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2023.1.PEDS22427"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Génome microbien",
"item": "https://questionsmedicales.fr/mesh/D064349"
},
{
"@type": "ListItem",
"position": 6,
"name": "Génome viral",
"item": "https://questionsmedicales.fr/mesh/D016679"
},
{
"@type": "ListItem",
"position": 7,
"name": "Gènes viraux",
"item": "https://questionsmedicales.fr/mesh/D005814"
},
{
"@type": "ListItem",
"position": 8,
"name": "Gènes vif",
"item": "https://questionsmedicales.fr/mesh/D016341"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gènes vif - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gènes vif",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gènes vif",
"description": "Comment diagnostiquer une mutation génétique ?\nQuels tests sont utilisés pour les gènes vif ?\nQuels symptômes indiquent un problème génétique ?\nPeut-on identifier des gènes vif par imagerie ?\nQuel rôle joue le conseil génétique ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gènes vif",
"description": "Quels sont les symptômes des maladies génétiques ?\nLes gènes vif causent-ils des symptômes spécifiques ?\nComment les symptômes évoluent-ils avec l'âge ?\nLes symptômes sont-ils héréditaires ?\nY a-t-il des symptômes communs aux gènes vif ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gènes vif",
"description": "Peut-on prévenir les maladies génétiques ?\nQuel rôle joue le dépistage précoce ?\nLes vaccinations aident-elles à prévenir des maladies génétiques ?\nComment le mode de vie influence-t-il les gènes ?\nLes conseils génétiques aident-ils à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gènes vif",
"description": "Quels traitements existent pour les maladies génétiques ?\nLa thérapie génique est-elle efficace ?\nQuels médicaments ciblent les gènes vif ?\nLes traitements sont-ils personnalisés ?\nComment gérer les symptômes au quotidien ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gènes vif",
"description": "Quelles complications peuvent survenir avec des gènes vif ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles prévisibles ?\nQuel suivi médical est nécessaire pour les complications ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gènes vif",
"description": "Quels sont les facteurs de risque pour les maladies génétiques ?\nL'âge des parents influence-t-il les risques ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nL'exposition à des toxines influence-t-elle les gènes ?\nLe mode de vie peut-il affecter les risques génétiques ?",
"url": "https://questionsmedicales.fr/mesh/D016341?mesh_terms=Regression+Analysis&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une mutation génétique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par séquençage génétique et tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les gènes vif ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le séquençage de l'ADN et l'analyse de l'expression génique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème génétique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des malformations, des troubles métaboliques ou neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des gènes vif par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à détecter des anomalies, mais ne révèle pas les gènes directement."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à comprendre les risques et les implications des mutations."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des maladies génétiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, incluant fatigue, douleurs, anomalies physiques ou cognitives."
}
},
{
"@type": "Question",
"name": "Les gènes vif causent-ils des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains gènes vif sont liés à des traits ou maladies spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou apparaître avec l'âge, selon la maladie."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils héréditaires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux symptômes liés à des gènes vif peuvent être héréditaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes communs aux gènes vif ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des troubles du développement ou des anomalies métaboliques peuvent être communs."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies génétiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies peuvent être prévenues par des tests génétiques et des conseils."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le dépistage précoce ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce permet d'identifier les risques et d'intervenir rapidement."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir des maladies génétiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas les maladies génétiques, mais les infections."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il les gènes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire l'expression de certains gènes liés à des maladies."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques aident-ils à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils fournissent des informations sur les risques et les options de prévention."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les maladies génétiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie génique, les médicaments et la gestion des symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certaines maladies, mais les résultats varient selon le cas."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent les gènes vif ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments spécifiques peuvent cibler des voies métaboliques ou des protéines défectueuses."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction du profil génétique du patient."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes au quotidien ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des soins symptomatiques, une nutrition adaptée et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des gènes vif ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies chroniques, des troubles métaboliques ou neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en limitant les activités et en causant des douleurs."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prédites par des tests génétiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est nécessaire pour les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour surveiller et gérer les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'environnement et des mutations spontanées."
}
},
{
"@type": "Question",
"name": "L'âge des parents influence-t-il les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut augmenter le risque de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle les gènes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines peut provoquer des mutations et affecter les gènes."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les risques génétiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut exacerber les risques de maladies liées aux gènes."
}
}
]
}
]
}
Reference intervals, which define an interval in which a specific proportion of measurements from a healthy population are expected to fall, are commonly used in medical practice. Synthesizing informa...
With the availability of individual participant data (IPD), non-parametric methods can be used to estimate reference intervals without any distributional assumptions. Furthermore, patient-level covari...
We compared several non-parametric bootstrap methods through simulation studies to account for within-study correlation. Under fixed effects model, we recommend keeping the studies fixed and only rand...
We proposed to use the quantile regression in the IPD meta-analysis to estimate the reference interval. Based on the simulation results, we identify an optimal bootstrap strategy for estimating the un...
Healthcare expenditure of road traffic injuries in China has not been adequately investigated so far. We aim to provide comprehensive information about the hospitalization costs of inpatients who suff...
We extracted the data of all inpatients (n = 60535) with road traffic injuries during the year 2019 from Chinese National Health Statistics Network Reporting System database in Hunan, China. We calcul...
The median hospitalization cost was $853.48, and the median length of hospital stay was 9 days. Vulnerable road users accounted for 84.9 % of all cases. Medicine cost is the first driver of hospitaliz...
Road traffic injuries cause huge healthcare costs for victims, most of whom are vulnerable road users. The total cost of hospitalization is incurred mainly for medicine, consumables, diagnosis, medica...
New-onset or worsening tricuspid regurgitation (TR) is a well-established complication encountered after cardiac implantable electronic devices (CIEDs). However, there are limited and conflicting data...
Schizophrenia patients often show obsessive-compulsive symptoms (OCS) and obsessive-compulsive disorder (OCD) and their presence has been associated with poorer prognosis. However, the impact of OCS/O...
A systematic review and meta-analysis (SRMA) of studies comparing the severity of psychotic symptoms among schizophrenia patients with and without OCS/OCD was performed. Standardized mean difference (...
Sixty-seven studies involving 7740 patients were included. Patients with schizophrenia and OCS/OCD showed a slightly higher severity of positive (SMD = 0.17, p value = 0.0089) and global psychotic sym...
Comorbid OCS/OCD in schizophrenia has, at most, a minor impact on psychotic severity. Variability in this effect was considerable and was poorly explained by the covariates analyzed....
Despite growing published evidence of the merits of endoscopic third ventriculostomy (ETV) instead of shunt revision at the time of shunt malfunction (secondary ETV), concerns about its efficacy and c...
In accordance with the PRISMA guidelines, systematic searches of Medline, Embase, and Cochrane Central were undertaken from database inception to September 7, 2022. ETV success was defined as the lack...
Sixteen studies reporting on 584 patients who underwent secondary ETV for shunt malfunction were included in the meta-analysis. The overall pooled mean (95% CI) age was 6.1 (3-9) years, and 57.0% of p...
This meta-analysis demonstrates that secondary ETV after shunt malfunction in pediatric patients is a feasible option with acceptable success rates and low complication rates. Clinical trial registrat...
In order to solve the complex and recurrent problem of chronic pelvic inflammation disease (CPID) in the process of the clinical treatment, a method of understanding the influencing factors of CPID by...
Based on an analysis of 643 listed firms in clean technology sectors, this study explores the nonlinear impact of the government's environmental attention (GEA) on firms' green innovation by exploitin...
Pakistan is currently experiencing a double burden of disease. Families with members having both communicable and noncommunicable diseases are at a greater risk of impoverishment due to enormous out-o...
The study extracted a sample of 6,775 households with at least one member experiencing both communicable and noncommunicable diseases from the Household Integrated Economic Survey 2018-19. The dataset...
Overall, 28.5% of households had double disease in 2018-19. The households with uneducated heads, male heads, outpatient healthcare, patients availing public sector healthcare services, and rural and ...
The coexistence of communicable and noncommunicable diseases is associated with excessive private healthcare costs in Pakistan. The results call for addressing the variations in financial costs associ...
There is a rapidly growing body of evidence for the application of virtual reality (VR) in pain management, however, with varying effectiveness. Little is known about patient-related and VR-related fa...
To evaluate the incidence and mortality trend of thyroid cancer, and compare its global incidence trends among different countries by age group and sex....
Data on age-standardized incidence and mortality rate of thyroid cancer among 50 countries were collected from the Cancer Incidence in Five Continents Volume XI; the Surveillance, Epidemiology, and En...
The age-standardized incidence of thyroid cancer was 3.1 and 10.1 cases per 100,000 persons in men and women, respectively. The incidence of thyroid cancer increased in most countries among individual...
An increasing incidence of thyroid cancer was observed in younger subjects in a majority of countries, highlighting the need for more preventive strategies in this population and possible avoidance of...